Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment

Core Viewpoint - Royal Philips is proposing new appointments and re-appointments to its Supervisory Board, including the appointment of John DeFord and the re-appointment of existing members, as part of its strategic focus on innovation and leadership in health technology [2][5][9]. Group 1: New Appointment - John DeFord is proposed as a new member of the Supervisory Board, recognized for his extensive experience in the medical device industry and expertise in regulatory affairs and quality systems [2][3]. - DeFord currently serves as Chairman and CEO of Samothrace Medical Innovations and has held senior leadership roles at Becton Dickinson and C.R. Bard [4]. Group 2: Re-appointments - The Supervisory Board recommends the re-appointment of Paul Stoffels, Herna Verhagen, and Sanjay Poonen, citing their valuable contributions and strong track records in medical and health technology [5][6]. - These re-appointments are seen as essential for advancing Philips' strategic priorities, including innovation and patient safety [6]. Group 3: Leadership Changes - Marc Harrison will step down from the Supervisory Board after serving two consecutive terms since 2018 [7]. - Roy Jakobs is proposed for re-appointment as President/CEO and Chairman, reflecting the Supervisory Board's confidence in his leadership and the progress made since 2022 [9]. Group 4: Company Overview - Royal Philips is a leading health technology company focused on improving health and well-being through innovation, generating EUR 18 billion in sales in 2025 and employing approximately 64,800 people [14].